104 related articles for article (PubMed ID: 22738401)
1. Role of electrostatics in differential binding of RalGDS to Rap mutations E30D and K31E investigated by vibrational spectroscopy of thiocyanate probes.
Ragain CM; Newberry RW; Ritchie AW; Webb LJ
J Phys Chem B; 2012 Aug; 116(31):9326-36. PubMed ID: 22738401
[TBL] [Abstract][Full Text] [Related]
2. Vibrational Stark effect spectroscopy at the interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an electrostatic mechanism for protein-protein interaction.
Stafford AJ; Ensign DL; Webb LJ
J Phys Chem B; 2010 Nov; 114(46):15331-44. PubMed ID: 20964430
[TBL] [Abstract][Full Text] [Related]
3. Conserved electrostatic fields at the Ras-effector interface measured through vibrational Stark effect spectroscopy explain the difference in tilt angle in the Ras binding domains of Raf and RalGDS.
Walker DM; Wang R; Webb LJ
Phys Chem Chem Phys; 2014 Oct; 16(37):20047-60. PubMed ID: 25127074
[TBL] [Abstract][Full Text] [Related]
4. Factors determining electrostatic fields in molecular dynamics simulations of the Ras/effector interface.
Ensign DL; Webb LJ
Proteins; 2011 Dec; 79(12):3511-24. PubMed ID: 21748802
[TBL] [Abstract][Full Text] [Related]
5. Electrostatic effects of mutations of Ras glutamine 61 measured using vibrational spectroscopy of a thiocyanate probe.
Stafford AJ; Walker DM; Webb LJ
Biochemistry; 2012 Apr; 51(13):2757-67. PubMed ID: 22385209
[TBL] [Abstract][Full Text] [Related]
6. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.
Spaargaren M; Bischoff JR
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12609-13. PubMed ID: 7809086
[TBL] [Abstract][Full Text] [Related]
7. The activation of RalGDS can be achieved independently of its Ras binding domain. Implications of an activation mechanism in Ras effector specificity and signal distribution.
Linnemann T; Kiel C; Herter P; Herrmann C
J Biol Chem; 2002 Mar; 277(10):7831-7. PubMed ID: 11748241
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator.
Kishida S; Koyama S; Matsubara K; Kishida M; Matsuura Y; Kikuchi A
Oncogene; 1997 Dec; 15(24):2899-907. PubMed ID: 9416833
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS.
Shirouzu M; Morinaka K; Koyama S; Hu CD; Hori-Tamura N; Okada T; Kariya K; Kataoka T; Kikuchi A; Yokoyama S
J Biol Chem; 1998 Mar; 273(13):7737-42. PubMed ID: 9516482
[TBL] [Abstract][Full Text] [Related]
10. High-pressure NMR study of the complex of a GTPase Rap1A with its effector RalGDS. A conformational switch in RalGDS revealed from non-linear pressure shifts.
Inoue K; Maurer T; Yamada H; Herrmann C; Horn G; Kalbitzer HR; Akasaka K
FEBS Lett; 2001 Oct; 506(3):180-4. PubMed ID: 11602241
[TBL] [Abstract][Full Text] [Related]
11. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation.
Matsubara K; Kishida S; Matsuura Y; Kitayama H; Noda M; Kikuchi A
Oncogene; 1999 Feb; 18(6):1303-12. PubMed ID: 10022812
[TBL] [Abstract][Full Text] [Related]
13. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
[TBL] [Abstract][Full Text] [Related]
14. Optimizing electrostatic field calculations with the adaptive Poisson-Boltzmann Solver to predict electric fields at protein-protein interfaces. I. Sampling and focusing.
Ritchie AW; Webb LJ
J Phys Chem B; 2013 Oct; 117(39):11473-89. PubMed ID: 24041016
[TBL] [Abstract][Full Text] [Related]
15. Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II.
Xu J; Shi S; Matsumoto N; Noda M; Kitayama H
Cell Signal; 2007 Jul; 19(7):1575-82. PubMed ID: 17382517
[TBL] [Abstract][Full Text] [Related]
16. Post-translational modifications of Ras and Ral are important for the action of Ral GDP dissociation stimulator.
Hinoi T; Kishida S; Koyama S; Ikeda M; Matsuura Y; Kikuchi A
J Biol Chem; 1996 Aug; 271(33):19710-6. PubMed ID: 8702675
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
Chen JM; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
[TBL] [Abstract][Full Text] [Related]
18. Ras/Rap effector specificity determined by charge reversal.
Nassar N; Horn G; Herrmann C; Block C; Janknecht R; Wittinghofer A
Nat Struct Biol; 1996 Aug; 3(8):723-9. PubMed ID: 8756332
[TBL] [Abstract][Full Text] [Related]
19. Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.
Esser D; Bauer B; Wolthuis RM; Wittinghofer A; Cool RH; Bayer P
Biochemistry; 1998 Sep; 37(39):13453-62. PubMed ID: 9753431
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
